{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:04Z","timestamp":1791328024614,"version":"4.3.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T00:00:00Z","timestamp":1237334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00262-009-0691-x","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T05:38:51Z","timestamp":1237268331000},"page":"1801-1807","source":"Crossref","is-referenced-by-count":57,"title":["Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer"],"prefix":"10.1007","volume":"58","author":[{"given":"Ichiya","family":"Honma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,18]]},"reference":[{"key":"691_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1074-7613(00)80028-X","volume":"10","author":"SA Rosenberg","year":"1999","unstructured":"Rosenberg SA (1999) A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10:281\u2013287","journal-title":"Immunity"},{"key":"691_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917\u2013921","journal-title":"Nat Med"},{"key":"691_CR3","first-page":"5071","volume":"58","author":"H Kawasaki","year":"1998","unstructured":"Kawasaki H, Altieri DC, Lu CD et al (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071\u20135074","journal-title":"Cancer Res"},{"key":"691_CR4","first-page":"5315","volume":"58","author":"I Tamm","year":"1998","unstructured":"Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315\u20135320","journal-title":"Cancer Res"},{"key":"691_CR5","first-page":"1731","volume":"8","author":"Y Hirohashi","year":"2002","unstructured":"Hirohashi Y, Torigoe T, Maeda A et al (2002) An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 8:1731\u20131739","journal-title":"Clin Cancer Res"},{"key":"691_CR6","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-03-0817","volume":"11","author":"S Idenoue","year":"2005","unstructured":"Idenoue S, Hirohashi Y, Torigoe T et al (2005) A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res 11:1474\u20131482","journal-title":"Clin Cancer Res"},{"key":"691_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-2-19","volume":"2","author":"T Tsuruma","year":"2004","unstructured":"Tsuruma T, Hata F, Torigoe T et al (2004) Phase I clinical study of anti-apoptosis protein, survivinderived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer. J Transl Med 2:19\u201329","journal-title":"J Transl Med"},{"key":"691_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1479-5876-6-24","volume":"6","author":"T Tsuruma","year":"2008","unstructured":"Tsuruma T, Iwayama Y, Ohmura T et al (2008) Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer. J Transl Med 6:24","journal-title":"J Transl Med"},{"key":"691_CR9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.urology.2005.11.052","volume":"67","author":"H Kitamura","year":"2006","unstructured":"Kitamura H, Torigoe T, Honma I et al (2006) Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy. Urology 67:955\u2013959","journal-title":"Urology"},{"key":"691_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1479-5876-4-42","volume":"4","author":"YT Koh","year":"2006","unstructured":"Koh YT, Higgins SA, Weber JS et al (2006) Immunological consequences of using three different clinical\/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund\u2019s adjuvant. J Trans Med 4:42","journal-title":"J Trans Med"},{"key":"691_CR11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman JD, Moss PA, Goulder PJ et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94","journal-title":"Science"},{"key":"691_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(02)00329-0","volume":"20","author":"Y Sato","year":"2002","unstructured":"Sato Y, Sahara H, Tsukahara T et al (2002) Improved generation of HLA class\/peptide tetramers. J Immunol Methods 20:177\u2013184","journal-title":"J Immunol Methods"},{"key":"691_CR13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.169.3.1611","volume":"169","author":"Y Sato","year":"2002","unstructured":"Sato Y, Nabeta Y, Tsukahara T et al (2002) Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma. J Immunol 169:1611\u20131618","journal-title":"J Immunol"},{"key":"691_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0039.1996.tb02520.x","volume":"47","author":"Y Date","year":"1998","unstructured":"Date Y, Kimura A, Kato H et al (1998) DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 47:93\u2013101","journal-title":"Tissue Antigens"},{"key":"691_CR15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"FO Nestle","year":"1998","unstructured":"Nestle FO, Alijagic S, Gilliet M et al (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4:328\u2013332","journal-title":"Nat Med"},{"key":"691_CR16","first-page":"5964","volume":"61","author":"MH Andersen","year":"2001","unstructured":"Andersen MH, Pedersen LO, Capeller B et al (2001) Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res 61:5964\u20135968","journal-title":"Cancer Res"},{"key":"691_CR17","first-page":"947","volume":"28","author":"T Ojima","year":"2006","unstructured":"Ojima T, Iwahashi M, Nakamura M et al (2006) The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Int J Oncol 28:947\u2013953","journal-title":"Int J Oncol"},{"key":"691_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3083.2006.01728.x","volume":"63","author":"IM Svane","year":"2006","unstructured":"Svane IM, Nikolajsen K, Walter MR et al (2006) Characterization of monocyte-derived dendritic cells maturated with IFN-alpha. Scand J Immunol 63:217\u2013222","journal-title":"Scand J Immunol"},{"key":"691_CR19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.4049\/jimmunol.179.3.1803","volume":"179","author":"T Kurotaki","year":"2007","unstructured":"Kurotaki T, Tamura Y, Ueda G et al (2007) Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol 179:1803\u20131813","journal-title":"J Immunol"},{"key":"691_CR20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","volume":"60","author":"Y Kumagai","year":"2008","unstructured":"Kumagai Y, Takeuchi O, Akira S (2008) TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60:795\u2013804","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0691-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-009-0691-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0691-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:33:19Z","timestamp":1558701199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-009-0691-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,18]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1007\/s00262-009-0691-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,18]]}}}